comparemela.com

Latest Breaking News On - Standard biotools inc - Page 5 : comparemela.com

Standard BioTools to Participate in Upcoming Investor Conferences - Standard BioTools (NASDAQ:LAB)

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that

United statesMichael egholmFluidigm corporationStandard biotools incResearch useAnnual healthcare conferenceChief executive officerBanc capital markets life sciencesMedtech investor forumInvestor relationsStandard biotools investor relationsStandard biotoolsMass cytometry

Global Microfluidic Devices Market to Surge to US$ 45 18 Billion by 2030 with Technological Advancements Driving Growth

/PRNewswire/ The "Global Microfluidic Devices Market (By Device Type, Material, Application, Industry and Region), Key Company Profiles, Trends, SWOT.

United statesMico biomedKoninklijke philipsLaura woodAsia pacificOffice hours callRevvity incStandard biotools incIllumina incNanoentek incE st office hours callAbbott laboratoriesAgilent technologies incAbaxis incMicropoint biotechnologies co ltdQuidelortho corporation

Global Microfluidic Devices Market to Surge to US$ 45 18

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) The

United statesAsia pacificKoninklijke philipsMico biomedAline incHamilton companyQuidelortho corporationNanoentek incKey company profilesStandard biotools incSiloam biosciences incMicropoint biotechnologies co ltdIllumina incPerkinelmer incThermo fisher scientific incHealth inc

Flow Cytometry in Oncology and Immunology Market Set for

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) The

United statesSysmex partec gmbMiltenyi biotecDanaher corporationBeckman coulter incAgilent technologies incHealth incBio rad laboratories incCell signaling technology incNexcelom bioscienceMerck kgaBecton dickinsonSony biotechnology incThermo fisher scientific incCytek biosciences incMerck kgaa

20,394 Shares in Standard BioTools Inc (NASDAQ:LAB) Bought by Freedom Wealth Alliance LLC

Freedom Wealth Alliance LLC purchased a new position in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 20,394 shares of the company’s stock, valued at approximately $59,000. A number of other hedge funds have […]

Casdin capitalMarshall waceStandard biotools incFreedom wealth allianceExchange commissionWalleye capitalStandard biotoolsFree reportCapital partnersGet free reportBiotools incVisit holdingschannelStandard biotools dailyNasdaq labSec filingsHedge fund holdings

vimarsana © 2020. All Rights Reserved.